Surgical Risk on Patients with Coagulopathies: Guidelines on Hemophiliac Patients for Oro-Maxillofacial Surgery.

Factor VIII / genetics Hemophilia A / complications Humans Oral Surgical Procedures / adverse effects Practice Guidelines as Topic Risk Factors
coagulopathies guidelines haemophilia maxillo-facial oral surgery

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
17 04 2019
Historique:
received: 18 02 2019
revised: 29 03 2019
accepted: 10 04 2019
entrez: 20 4 2019
pubmed: 20 4 2019
medline: 29 10 2019
Statut: epublish

Résumé

Haemophilia is a disease of genetic origin, which causes a defect in blood coagulation. Under normal conditions, in the case of leakage from the blood vessels, the blood forms a clot that reduces or blocks the bleeding. This process involves the activation of several plasma proteins in a cascade-like species. Two of these proteins, produced in the liver, factor VIII and factor IX, are deficient or present a functional defect in people with haemophilia. Because of this deficit, the haemophiliacs easily suffer external and internal bleeding. Surgical treatment of these patients is to be observed, and often their treatment is delayed due to unclear guidelines and risks in treating these patients. The aim is to provide clear guidelines in the case of surgical treatment of these patients. In this study, we have considered all the guidelines that refer to the gold-maxillofacial surgery, focusing on the literature of the last 10 years. Surely, this collection of guidelines will favor the choice of the clinician towards safer and predictable protocols. This study does not want to create a guideline but evaluates the literature of the last 10 years, and highlights the latest for the treatment of these patients., with the aim of informing the pathology and at the same time making the surgical maneuvers safer. Despite the research of literature has produced few results, it was nevertheless possible to draw up a guideline thanks to additional information extrapolated from textbooks and other scientific articles. According to the guidelines, it is possible to proceed to the treatment of these patients, if with appropriate therapy in a safe and risk-free manner.

Sections du résumé

BACKGROUND
Haemophilia is a disease of genetic origin, which causes a defect in blood coagulation. Under normal conditions, in the case of leakage from the blood vessels, the blood forms a clot that reduces or blocks the bleeding. This process involves the activation of several plasma proteins in a cascade-like species. Two of these proteins, produced in the liver, factor VIII and factor IX, are deficient or present a functional defect in people with haemophilia. Because of this deficit, the haemophiliacs easily suffer external and internal bleeding. Surgical treatment of these patients is to be observed, and often their treatment is delayed due to unclear guidelines and risks in treating these patients. The aim is to provide clear guidelines in the case of surgical treatment of these patients.
METHODS
In this study, we have considered all the guidelines that refer to the gold-maxillofacial surgery, focusing on the literature of the last 10 years.
RESULTS
Surely, this collection of guidelines will favor the choice of the clinician towards safer and predictable protocols. This study does not want to create a guideline but evaluates the literature of the last 10 years, and highlights the latest for the treatment of these patients., with the aim of informing the pathology and at the same time making the surgical maneuvers safer.
CONCLUSIONS
Despite the research of literature has produced few results, it was nevertheless possible to draw up a guideline thanks to additional information extrapolated from textbooks and other scientific articles. According to the guidelines, it is possible to proceed to the treatment of these patients, if with appropriate therapy in a safe and risk-free manner.

Identifiants

DOI: 10.3390/ijerph16081386 PMID: 30999657 PMC: PMC6518229
pubmed: 30999657
pii: ijerph16081386
doi: 10.3390/ijerph16081386
pmc: PMC6518229
pii:
doi:

Substances chimiques

F8 protein, human 839MOZ74GK
Factor VIII 9001-27-8

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors report no conflicts of interest related to this study.

Références

Semin Thromb Hemost. 2017 Sep;43(6):639-641
pubmed: 28609796
Haemophilia. 2013 Jul;19(4):583-9
pubmed: 23560720
Nature. 2014 Nov 27;515(7528):S157
pubmed: 25427203
Haemophilia. 2018 Sep;24(5):e344-e353
pubmed: 30004620
Int J Mol Sci. 2018 Jun 13;19(6):
pubmed: 29899263
Cochrane Database Syst Rev. 2015 Feb 09;(2):CD009961
pubmed: 25922858
Nature. 2014 Nov 27;515(7528):S158-9
pubmed: 25427204
Chin J Traumatol. 2017 Feb;20(1):4-8
pubmed: 28209449
Blood Coagul Fibrinolysis. 2015 Dec;26(8):978-80
pubmed: 26484644
Blood Transfus. 2013 Apr;11(2):178-82
pubmed: 22790275
Lancet. 2013 Nov 16;382(9905):1678
pubmed: 24238556
Minerva Stomatol. 2015 Feb;64(1):21-46
pubmed: 25660591
J Int Soc Prev Community Dent. 2017 Jan-Feb;7(1):64-68
pubmed: 28316952
Haemophilia. 2011 Nov;17(6):895-905
pubmed: 21535320
Evid Based Dent. 2017 Mar;18(1):28-29
pubmed: 28338025
J Clin Med. 2017 Mar 19;6(3):
pubmed: 28335488
Orphanet J Rare Dis. 2012 May 02;7:24
pubmed: 22551339
Lancet. 2012 Jul 21;380(9838):216-7
pubmed: 22817972
Int J Mol Sci. 2018 Jun 29;19(7):
pubmed: 29966238
Medicina (Kaunas). 2015;51(1):46-56
pubmed: 25744775
J Oral Implantol. 2017 Feb;43(1):45-50
pubmed: 27759503
Semin Thromb Hemost. 2016 Sep;42(6):689-92
pubmed: 27472424
Indian J Dent Res. 2012 Nov-Dec;23(6):763-9
pubmed: 23649060
J Clin Med. 2017 Mar 20;6(3):
pubmed: 28335525
Haemophilia. 2018 Sep;24(5):693-702
pubmed: 29944195
Chin J Traumatol. 2017 Feb;20(1):9-13
pubmed: 28202368
J Clin Med. 2017 Jul 31;6(8):
pubmed: 28758960
Pharmaceutics. 2017 Oct 17;9(4):
pubmed: 29039750
Minerva Psichiatr. 1995 Jun;36(2):79-82
pubmed: 7643737
Open Dent J. 2018 Mar 30;12:219-229
pubmed: 29682092
Molecules. 2018 Jun 15;23(6):
pubmed: 29914049
Mar Drugs. 2018 Jan 13;16(1):
pubmed: 29342834
Dis Markers. 2019 Mar 25;2019:8040361
pubmed: 31019584
Minerva Stomatol. 2017 Feb;66(1):1-8
pubmed: 27716739
J Geriatr Cardiol. 2015 Sep;12(5):575-9
pubmed: 26512250
J Clin Med. 2017 Jun 25;6(7):
pubmed: 28672826
Biomed Res Int. 2018 Nov 4;2018:9352130
pubmed: 30519592
Blood Coagul Fibrinolysis. 2016 Oct;27(7):812-816
pubmed: 26761584
Science. 2009 Nov 6;326(5954):817
pubmed: 19815722
Open Dent J. 2017 Aug 30;11:460-465
pubmed: 28979575
Stomatologiia (Mosk). 2012;91(2):9-11
pubmed: 22810565
Int J Adolesc Med Health. 2015 Aug;27(3):311-7
pubmed: 25720040
Sensors (Basel). 2018 Jul 26;18(8):
pubmed: 30050026
J Clin Med. 2017 Nov 22;6(11):
pubmed: 29165342

Auteurs

Luigi Laino (L)

Multidisciplinary Department of Medical-Surgical and Odontostomatological Specialties, University of Campania "Luigi Vanvitelli", 80100 Napoli, Italy. luigi.laino@unicampania.it.

Marco Cicciù (M)

Department of Biomedical and Dental Sciences and Morphological and Functional Imaging, Messina University, 98100 Messina, Italy. acromarco@yahoo.it.

Luca Fiorillo (L)

Multidisciplinary Department of Medical-Surgical and Odontostomatological Specialties, University of Campania "Luigi Vanvitelli", 80100 Napoli, Italy. lfiorillo@unime.it.
Department of Biomedical and Dental Sciences and Morphological and Functional Imaging, Messina University, 98100 Messina, Italy. lfiorillo@unime.it.

Salvatore Crimi (S)

Department of Biomedical and Surgical and Biomedical Sciences Catania University, 95125 Catania, Italy. torecrimi@gmail.com.

Alberto Bianchi (A)

Department of Biomedical and Surgical and Biomedical Sciences Catania University, 95125 Catania, Italy. alberto.bianchi@unict.it.

Giulia Amoroso (G)

Department of Biomedical and Dental Sciences and Morphological and Functional Imaging, Messina University, 98100 Messina, Italy. amoroso.giulia@hotmail.it.

Ines Paola Monte (IP)

Department of General Surgery and Medical-Surgery Specialties, University of Catania, 95125 Catania, Italy. inemonte@unict.it.
Department of Cardio-Thorax-Vascular and Transplant, A.O.U. Policlinico Catania, 95125 Catania, Italy. inemonte@unict.it.

Alan Scott Herford (AS)

Department of Maxillofacial Surgery, Loma Linda University, Loma Linda, CA 92350, USA. aherford@llu.edu.

Gabriele Cervino (G)

Department of Biomedical and Dental Sciences and Morphological and Functional Imaging, Messina University, 98100 Messina, Italy. amoroso.giulia@hotmail.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Facteurs de la coagulation sanguine › Facteur VIII › Surgical Risk on Patients with Coagulopathies:...
questionsmedicales.fr › Malformations et maladies congénitales, héréditaires et néonatales › Maladies génétiques congénitales › Troubles héréditaires de la coagulation sanguine › Hémophilie A › Surgical Risk on Patients with Coagulopathies:...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Surgical Risk on Patients with Coagulopathies:...
questionsmedicales.fr › Procédures de chirurgie maxillofaciale et buccodentaire › Surgical Risk on Patients with Coagulopathies:...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Assurance de la qualité des soins de santé › Recommandations comme sujet › Guides de bonnes pratiques cliniques comme sujet › Surgical Risk on Patients with Coagulopathies:...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Surgical Risk on Patients with Coagulopathies:...